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Abstract: Phase I-II detoxification and antioxidant enzymes are responsible for the detoxification and elimination of acti-
vated carcinogens, acting as important biomarkers for chemoprevention. Among them, cytochrome P450s plays a prominent 
role in the metabolic activation of xenobiotics. The herb Salicornia freitagii (SF) (Amaranthaceae) is known for its anticancer, 
antioxidant, antidiabetic and antiinflammatory activities. In this study, we determined the bioactive phenolics in the SF 
methanol extract and investigated its antiproliferative potential in HT-29 human colon cancer cells. We also investigated 
the modulation of some phase I and II enzyme (CYP 1A1, 1A2, 2E1, GSTP1 and GPx) mRNA expression and enzymatic 
activities by the SF extract and its major bioactive phenolic compounds. LC/MS-MS analysis showed that the main phenolic 
compounds of the methanolic SF extract are vanillic acid (48 µg/100g) and p-coumaric acid (10.8 µg/100g). SF extract, 
vanillic acid and p-coumaric acid exhibited high antiproliferative activities in HT-29 cells, with IC50 values of 81.79µg/mL, 
98.8 µM and 221.6 µM, respectively. The mRNA expression levels of CYP1A2 and CYP2E1 were decreased, while those of 
GSTP1 and GPx in HT-29 cells were increased after application of either the SF extract or vanillic acid. The SF extract by 
itself also increased the activities of GPx and GSTP1 enzymes 1.68- and 1.49-fold, respectively. Our data indicate that the 
SF extract and its major bioactive compound, vanillic acid, could exert a modulatory effect on the expression of enzymes 
that are involved in xenobiotic activation and detoxification pathways in the gastrointestinal tract. For this reason, SF can 
be considered as a natural source of chemopreventive agents.
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INTRODUCTION
Plant phytochemicals have gained importance in re-
cent years due to their diverse biological properties, 
including antioxidant, antimicrobial, antifungal and 
anticancer activities. Glassworts, a group of succu-
lent halophytic plants, belong to the Amaranthaceae 
family. They are consumed as vegetables and used as 
medicinal plants around the world. They have been 
classified in two different genera as Salicornia and Sar-
cocornia. Many epidemiological studies have revealed 
a relation between health benefits and the consump-
tion of glassworts [1-3]. Because they are rich sources 
of protein, vitamins, dietary fiber, essential fatty acids 
and minerals, they have become essential for human 
nutrition [4-7]. Glassworts have been reported to be 
rich sources of antioxidant compounds [8-11]. There-
fore, the significance of glassworts is not only due to 
their nutritive values but also because they are an ex-
cellent source of bioactive compounds that possess 
potentially important therapeutic effects, such as an-
ticancer, antioxidant, antihyperlipidemic, antidiabetic 
and antiinflammatory activities [12-15]. Glassworts 
are used for the treatment of intestinal ailments, ne-
phropathy, cancer, asthma, arthritis, hepatitis, hyper-
tension and hemorrhoids [16,17]. Colorectal cancer, 
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which is the third most common cancer type world-
wide and the fourth leading cause of cancer-related 
death, is diagnosed in over one million new cases per 
year [18]. As most gastrointestinal system cancers are 
highly linked to dietary habits, they are considered to 
be preventable [19].
By bioactivating a variety of xenobiotics, including 
drugs, food additives, industrial solvents and pollut-
ants, to highly reactive and mutagenic metabolites, 
the cytochrome P450 (CYP) monooxygenase system 
assumes a key role in toxicity and carcinogenesis 
[20]. Although the main function of CYP enzymes 
is detoxification of xenobiotics, many CYP isoforms 
catalyze the metabolic activation of procarcinogens to 
their ultimate carcinogenic forms [21]. The induction 
of some CYP1A isozymes that metabolize a variety of 
polycyclic aromatic hydrocarbons (PAHs), is mediated 
by the aryl hydrocarbon receptor (AhR), which is in-
volved in various biological processes [22]. Benzo[a]
pyrene (BaP) plays a major role in lung cancer de-
velopment. Conversion of inactive Benzo[a]pyrene 
(BaP) to the mutagenic metabolite BaP-7,8-diol-9,10-
epoxide, and the subsequent formation of DNA ad-
ducts mainly with deoxyguanosine is an example of 
the catalytic activity of CYP1A1 [23]. CYP2E metabo-
lizes many drugs, toxicants and carcinogens, such as 
acetaminophen, nitrosamines, phenol, benzene, 4-ni-
trophenol, carbon tetrachloride, chloroform, pyrazole 
and vinyl chloride [24,25]. The most prominent CYP 
isoforms expressed in colon tissue are CYP 1A1, 1A2, 
2E1 and 3A4 [26].
Phase II drug-metabolizing enzymes convert 
xenobiotics or active chemical carcinogens to less 
toxic or inactive metabolites that are readily elimi-
nated from the body [20]. Glutathione S-Transferases 
(GSTs) are phase II detoxifying enzymes that metabo-
lize electrophilic substrates containing carbon, nitro-
gen and sulfur atoms by conjugation reaction with the 
endogenous tripeptide glutathione (GSH), which re-
sults in the formation of less reactive and more water 
soluble products [27]. Some drugs, including cisplatin 
and carmustine, are substrates of GSTP1 and GSTM1, 
respectively, and are excreted by conjugation with glu-
tathione [28,29]. The enzyme glutathione peroxidase 
(GPx), catalyzes the reduction of hydrogen peroxides 
to water and alcohols at the expense of GSH [30]. It 
protects the organism from oxidative damage by re-
ducing fatty acid hydroperoxides, H2O2, phospholipid 
hydroperoxides and cholesterol hydroperoxides [31]. 
It was reported that GPx knockout mice were highly 
susceptible to oxidative stressors [32]. Cardiovascular 
diseases and stroke incidences were found to be highly 
increased in the absence of GPx [33].
In this context, the inhibition of CYP1A1, CYP1A2 
and CYP2E1 enzymes and the activation of GSTP1 
and GPx enzymes could represent a promising cancer 
chemoprevention strategy. Therefore, in this study we 
aimed to determine the major phenolic compounds 
of SF, to examine their antiproliferative effects and to 
elucidate their effects on several phase I, phase II and 
antioxidant enzymes in HT-29 cells.
MATERIALS AND METHODS
Chemicals
Compounds for cell culture studies were McCoy’s 5A 
medium with L-glutamine (Lonza, Belgium), sodium 
pyruvate (Lonza, Belgium), PBS (Lonza, Belgium), 
dimethyl sulfoxide (Appli Chem, Germany), Trypan 
blue (Biological Industries, Israel), RIPA buffer (Cell 
Signaling Technology, USA), nuclease-free water 
(Hyclone, USA), XTT Cell Proliferation kit (Biologi-
cal Industries, Israel), cDNA Synthesis Kit (Thermo 
Scientific, USA), Fast Start Universal SYBR Green 
ROX (ROCHE, Switzerland). All primers were de-
signed with NCBI BLAST and purchased from Ion-
tek (İstanbul, Turkey). Standard phenolic compounds 
were purchased from Sigma-Aldrich (USA).
Plant material and extract preparation
Naturally growing samples of the glasswort SF were 
collected from Şereflikoçhisar, Ankara Province, 
Turkey, in 2014. Voucher specimens are kept in the 
Laboratory of Seed Plant Systematic, Department of 
Biology, Ankara University, Turkey. The aerial parts 
of the plants were dried at room temperature and pro-
tected from direct exposure to sunlight. About 30 g of 
dried leaves were mixed with 250 mL of methanol and 
shaken overnight. This process was performed three 
times. To obtain ultra-dry powders, the methanol 
extract was concentrated under vacuum in a rotary 
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evaporator (Heidolph, Germany) and then freeze-
dried (Christ, Germany). The extracted powder was 
weighed and stored at -20°C in a brown bottle until 
further use.
Identification and quantification of phenolic 
compounds by LC-MS/MS
The methanol extract of SF was examined for its phe-
nolic content by liquid chromatography (Agilent 1200 
equipped with a micro degasser, autosampler and di-
ode array detector (DAD), connected to an Agilent 
6460 triple ion trap mass spectrometer via an electro-
spray interface). Separation was achieved on a Zorbax 
SB-C18 column (2.1x50 mm x 1.8 µm) at a flow rate 
of 0.3 mL/min at 35oC, using solvent A (0.05% for-
mic acid, 5 mM ammonium formate) and solvent B 
(methanol) as a mobile phase. A gradient system was 
performed and running time was 13 min. The DAD 
recorded the spectra from 180 to 800 nm. Standards 
were prepared in the range of 0.031 to 10 ppm. The 
extract was dissolved in methanol and filtered (0.22 
µm) to obtain a final concentration of 1mg/mL. The 
injection volume into the LC-MS/MS instrument was 
5 µL. Agilent G3793AA MassHunter Optimizer soft-
ware was used for data evaluation.
Cell culture
HT-29 human colon adenocarcinoma cells were ob-
tained from ATCC (American Type Culture Collec-
tion, LGC Promochem, UK). Cancer cells were grown 
in McCoy’s 5A medium containing 10% fetal bovine 
serum (FBS) and 1% penicillin-streptomycin (Pen 
Strep) solution. Cultures were incubated at 37°C with 
5% CO2 and 95% humidity. Cell culture studies were 
performed in a Metisafe Class II Safety Cabinet. 
Cytotoxicity assay
Antiproliferative activity tests were performed by 
measuring the cellular metabolic activity by the colori-
metric 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H 
tetrazolium-5-carboxanilide (XTT) assay. Cells were 
plated at a concentration of 1x105 cells/mL in 96-well 
culture plates and allowed to adhere overnight at 37°C. 
After 24 h, the cells were treated for 48 h with differ-
ent concentrations of extract (20-150 µg/mL), vanillic 
acid (50-200 µM) and p-coumaric acid (50-400 µM). 
After the incubation, the antiproliferative effects of 
the agents were evaluated using the XTT cell prolif-
eration kit (Biological Industries, Israel). Absorbance 
was measured at 415 nm with a Multiscan GO micro-
plate reader (Thermo Scientific, USA). Controls were 
treated with DMSO alone (0.2%). The results were ex-
pressed as IC50
 (µg/mL) for the extract and IC50 (µM) 
for the phenolic compounds, and all are presented as 
means±SEM of three independent experiments, each 
performed in triplicate.
RNA isolation, cDNA synthesis and quantitative 
real time qPCR
HT-29 cells (25x104 cells/mL) were seeded in 6-well 
plates and incubated for 24 h in a CO2 incubator at 
37oC. The following day, the medium was refreshed 
and the cells were treated with SF extract and its main 
bioactive components, vanillic and p-coumaric acid, 
at the concentrations of the determined IC50 values 
and incubated for 48 h. After incubation, isolation 
of total RNA was performed according to the Gene-
Jet RNA Purification Kit (Thermo Scientific USA). 
The isolated RNA was quantified by measuring the 
absorbance at 260 nm and its purity and quality were 
evaluated by measuring the 260/280 nm ratio. Reverse 
transcription of RNA to cDNA was performed us-
ing the RevertAid™ First Strand cDNA Synthesis Kit 
(Thermo Scientific USA) according to the manufac-
turer’s protocol. The synthesized cDNA was stored at 
-80oC until further use.
The effects of SF extract, vanillic acid and p-cou-
maric acid on the expression of selected genes in HT-
29 cells were studied by quantitative real-time PCR 
(qRT-PCR) using Corbett Rotor Gene 6000 (Corbett 
Life Science, Concorde, NSW, Australia). Ten µL of the 
final reaction mixture contained 1.6 µL cDNA (50-100 
ng), 0.2 µL of 10 µM of the forward primer, 0.2 µL of 
10 µM of the reverse primer, 5 µL of Maxima®SYBR 
Green qPCR Master Mix (Fermentas, Glen, Burnie, 
MD) and 3 µL of RNase-free distilled water. In order 
to check for genomic DNA contamination, NTC (no 
template control) was used during the reaction. As an 
internal standard, GAPDH was used. The qRT-PCR 
program consisted of the following cycling profile: ini-
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tial melting at 95°C for 10 min; the amplification and 
quantification program was repeated 40 times; melting: 
95°C for 20 s, annealing: 58-62°C (depending on the 
gene), as shown in Table 1, for 30 s; extension: 72°C 
for 20 s. In order to confirm the PCR product, melting 
curve analysis of the amplification product was carried 
out at the end of each amplification reaction.
Protein extraction
HT-29 cells (25x104 cell/ mL) were seeded in tissue 
culture plates for protein extraction. After 24 h, the 
cells were treated with the SF extract at a concentra-
tion corresponding to the IC50 (mg/mL) value and 
incubated for 48 h. Protein extraction was performed 
with 400 µL of 1X RIPA buffer containing1 mM phe-
nylmethanesulfonylfluoride (PMSF). The cells were 
scraped and lysed by sonication for 5 min and centri-
fuged at 14000xg for 10 min. The collected superna-
tant was stored at -80°C until further use. The protein 
concentration was determined according to the Lowry 
method [34].
Measurement of enzyme activities
GST activity was determined by monitoring thioether 
formation between 1-chloro-2,4-dinitrobenzene 
(CDNB), which served as the substrate, and GSH as 
a cofactor, at 340 nm [35]. Briefly, to a single well of 
a 96-well plate, 162.5 μL dH2O, 50 μL 500 mM phos-
phate buffer pH 7.4, 10 μL 25 mM GSH and 15 μL 
enzyme source (20-50 μg protein) were added. The 
reaction was started after the addition of 12.5 μL of 20 
mM CDNB and measured for 5 min. GST activity was 
expressed as nmol/min per mg protein; the extinction 
coefficient was 6.29 mM-1 cm-1.
GPx activity was measured according to [36], 
with some modifications. In a single well of a 96-well 
plate, 105 μL of 0.1 M Tris-HCl buffer (pH:8.0), 25 
μL of 3 mM GSH, 25 μL of 0.5 unit/mL glutathione 
reductase (GR) and 20 μL of the cytosolic fraction 
were added and incubated for 3 min. The reaction 
was started after the addition of 25 μL H2O2. Reac-
tions were measured for each well every 10 s for 4 min 
at 240 nm with a Multiskan™ GO spectrophotometer 
(Thermo Scientific, USA). GPx activity was expressed 
as nmol/min per mg protein; the extinction coefficient 
was 0.00373 mM-1 cm-1.
Statistical analysis
Statistical analyses were performed by Student’s t-test 
using the GraphPad Prism ver. 6 statistical software 
package for Windows. All results were expressed as 
means with their standard deviation (SD); p<0.05 was 
chosen as the minimum level for significance.
RESULTS
Characterization of SF extract by LC-MS/MS
Fig. 1A shows the chromatogram used to identify and 
quantify ten phenolic compounds, namely: vanillic 
acid, p-coumaric acid, caffeic acid, gallic acid, syringic 
acid, chlorogenic acid, rosmarinic acid, (-)-epicate-
chin (EC), epigallocatechin gallate (EGCG) and rutin 
trihydrate in the SF methanolic extract. LC-MS/MS 
analysis revealed that the SF methanol extract con-
tained high concentrations of vanillic acid (48 µg/100 
g extract) and p-coumaric acid (10.8 µg/100g extract), 
which were therefore by far the predominant phenolic 
compounds of all of the phenolics (Fig. 1B). All other 
phenolics were below the limit of quantification.
Cytotoxic activities 
The cell-growth inhibitory effects of the SF methanol 
extract and its bioactive components on HT-29 hu-
man adenocarcinoma cell lines were investigated by 
Table 1. Primer pairs used for amplification, with annealing tem-
peratures and sizes of the PCR products.
Gene  Sequences (5´– 3´) Size of PCR pruduct
Temp. (°C) (base pair)
GAPDH F→ GAGCGAGATCCCTCCAAAAT 60 197
R→ GGCTGTTGTCATACTTCTATGG
CYP1A1 F→ TACCTCAGCAGCCACCTCCAAG 63 121
R→ GGCCCTGATTACCCAGAATACC
CYP1A2 F→ ATGCTCAGCCTCGTGAAGAAC 60 96
R→ GTTAGGCAGGTAGCGAAGGAT
CYP2E1 F→ AGCGCTGCTGGACTACAAGG 62 184
R→ CCTCTGGATCCGGCTCTCAT
GPX-4 F→ GAGGCAAGACCGAAGTAAACTAC 60 100
R→ CCGAACTGGTTACACGGGAA
GSTp1 F→ CCTACACCGTGGTCTATTTCCC 60 136
R→ CAGGAGGCTTTGAGTGAGC
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the XTT assay. This has not been examined previously. 
The findings from the present study clearly demon-
strate that the extract, vanillic acid and p-coumaric 
acid can inhibit the proliferation of human cancer 
cells in a time- and concentration-dependent man-
ner (Fig. 2). The XTT assays revealed the absence of 
any antiproliferative effects of the SF extract on HT-
29 cells up to 24 h incubation. On the other hand, a 
48-h treatment showed that proliferation of the cells 
decreased critically in the presence of the SF extract 
in the range of 25 to 200 µg/mL. At 200 µg/mL, the 
extract displayed maximum antiproliferative activity, 
observed as a significant decrease in cell viability. Ad-
ditionally, vanillic acid and p-coumaric acid exhibited 
their cytotoxic activities against HT-29 cancer cells 
in the range of 25 to 500 µM. The IC50 values of SF 
extract, vanillic and p-coumaric acid were determined 
as 81.79 µg/mL, 98.8 µM and 221.6 µM, respectively.
The effects of the SF extract, vanillic acid and 
p-coumaric acid on different CYP isozyme and 
antioxidant enzyme mRNA expression in HT-29 
cells 
The presented data indicates that treatment of HT-
29 cells with the methanolic extract of SF and its 
major bioactive phenolic compounds, vanillic acid 
and p-coumaric acid, caused remarkable changes in 
the CYP1A1, CYP1A2, CYP2E1, GPx and GSTP1 
mRNA expression (Figs. 3 and 4). As can be seen 
in Fig. 3, after a 48-h incubation, CYP1A2 (Fig. 3B) 
and CYP2E1 (Fig. 3C) mRNA expression decreased 
4.75- and 1.66-fold, respectively (p<0.0001), whereas 
CYP1A1 mRNA expression increased 1.3-fold as 
compared to the control (p<0.005) (Fig. 3A). Vanillic 
acid, the major phenolic content of the SF extract, 
lowered CYP1A1 (Fig. 3A), CYP1A2 (Fig. 3B) and 
CYP2E1 (Fig. 3C) mRNA expression 1.33-, 2.49- and 
Fig. 1. LC-MS/MS chromatograms. A – standard polyphenols: 1 – gallic acid; 2 – chlorogenic 
acid; 3 – vanillic acid; 4 – caffeic acid; 5 – epigallocatechin gallate; 6 – epicatechin; 7 – syringic 
acid; 8 – p-coumaric acid; 9 – rosmarinic acid; 10 – rutin trihydrate. B – SF methanol extract: 
1 – vanillic acid; 2 – p-coumaric acid.
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1.62-fold, respectively (p<0.005). As for p-coumar-
ic acid, it did not exhibit any remarkable effect on 
CYP1A, CYP1A2 and CYP2E1 mRNA expression 
compared to the control group (p>0.05) (Fig. 3A, B, 
C, respectively). Moreover, incubation of HT-29 cells 
with the SF extract for 48 h increased GPx (Fig. 4A) 
and GSTP1 (Fig. 4B) mRNA expression 1.57- and 1.3-
fold, respectively (p<0.0005), compared to the control 
group. Vanillic acid increased GPx (Fig. 4A) and GST 
(Fig. 4B) mRNA expression 1.37- and 1.26-fold, re-
spectively (p<0.005). On the other hand, p-coumaric 
acid did not exhibit any considerable effect on GPx 
mRNA expression (Fig. 4A), but increased GSTP1 
mRNA expression (Fig. 4B) 1.25-fold in comparison 
to the control (p<0.005).
Effects of SF extract on enzyme activities of GPx 
and GSTP1 in HT-29 Cells 
Fig. 5 shows the effects of the SF extract on GPx (Fig. 
5A) and GSTP1 (Fig. 5B) enzyme activities in HT-29 
cells. The SF extract at the concentration correspond-
ing to IC50 increased cytosolic GPx activity 1.68-fold 
(p<0.005). The SF extract also increased the activity 
of cytosolic GSTP1 1.49-fold (p<0.005).
DISCUSSION
In recent years, traditional medicine such as herbal 
remedies or dietary supplements, have gained increas-
ing popularity, encouraging investigators to examine 
the actions of phytochemicals on xenobiotic metabo-
lism and their antioxidant, antitumor, anticarcino-
genic and antimutagenic effects. The major phenolic 
compounds in SF extracts have been reported to be 
Fig. 2. Concentration-dependent cytotoxic effects against HT-
29 cell lines after 48 h of treatment. SF extract (a); vanillic acid 
(b); p-coumaric acid (c). Each point represents the average of 
three independent measurements, each done in triplicate, with 
the means±SD.
Fig. 3. Effects of the SF extract, vanillic and p-coumaric acid treatments for 48 h on CYP1A1 (A) (p<0.005), CYP1A2 (B) (p<0.0001) 
and CYP2E1 (C) (p<0.005) mRNA expression in HT-29 cells. Alterations in mRNA expression were analyzed by qRT-PCR. Results are 
presented as the mean from three independent experiments (n≥3) and are expressed as relative means±SD. Effects of agents on mRNA 
levels of the tested genes were normalized to housekeeping GAPDH mRNA. Fold-inhibition was calculated using the following formula: 
2-∆∆Ct, where ∆∆Ct=∆Ct(treated)−∆Ct(control); ∆Ct(treated)=∆Ct(CYPs)−∆Ct(GAPDH); ∆Ct(control)=∆Ct(CYPs)−∆Ct(GAPDH).
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vanillic acid, p-coumaric acid, ferulic acid, caffeic acid, 
kaempferol and galangin [37]. Our SF methanol ex-
tract showed close similarities with the literature, dis-
playing high amounts of vanillic and p-coumaric acid.
It has been reported that some CYP1A and CYP2E 
enzymes are expressed at high levels in extrahepatic 
tissues, such as the colon and intestine, and deemed 
to be responsible for the formation of unique extrahe-
patic metabolites and resulting tissue-specific conse-
quences in cellular toxicity and organ pathology [26]. 
The expression of CYPs, phase II and antioxidant en-
zymes is controlled at the transcriptional and trans-
lational levels. The mRNA levels of CYP genes were 
shown to be affected by the expression of micro RNAs 
[38,39]. To examine aspects of the control mecha-
nism of these enzymes after exposure to SF extract 
and its major phenolic compound vanillic acid at the 
transcriptional and translational levels, we examined 
changes in mRNA expression and enzyme activities.
CYP1A1and CYP1A2 are the principal mem-
bers of the CYP1A family that are induced by PAHs 
and are also involved in the metabolic activation of 
PAHs and heterocyclic amines [40]. The metabolism 
of PAHs by members of the CYP1A family generates 
reactive products that irreversibly bind to protein and 
DNA, producing toxic and carcinogenic events [41]. 
It was reported that certain phenolic compounds/fla-
vonoids have roles in reducing cancer susceptibility, 
Fig. 4. Effects of SF extract, vanillic and p-coumaric acid treat-
ments for 48 h on GPx (p<0.0005) (A) and GSTP1 (p<0.0005) 
(B) mRNA expression in HT-29 cells. Alterations in mRNA ex-
pression were analyzed by qRT-PCR. Results are presented as the 
mean from three independent experiments (n≥3) and expressed 
as relative means±SD. Effects of agents on mRNA levels of the 
tested genes were normalized to housekeeping GAPDH mRNA. 
Fold-inhibition was calculated using the following formula: 2-∆∆Ct, 
where ∆∆Ct=∆Ct(treated)−∆Ct(control); ∆Ct(treated)=∆Ct(CY
Ps)−∆Ct(GAPDH); ∆Ct(control)=∆Ct(CYPs)−∆Ct(GAPDH).
Fig. 5. Effects of SF extract on the activities of antioxidant en-
zymes in HT-29 cells. A – GPx; B – GSTP1. Enzyme activities 
were determined as described in the Materials and Methods sec-
tion. Values are means±SD for triplicate determinations (n≥3). 
Significantly different from the control by two-tailed Student’s 
t-test – *p<0.05, ** p<0.001.
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especially by preventing the induction of CYP1A iso-
zymes [42,43]. In light of the role of CYP1A in the for-
mation of reactive products, the observed inhibition 
of CYP1A mRNA expression by the SF extract and its 
major phenolic component vanillic acid could lead to 
the reduction or prevention of the onset of many dis-
eases, including cancer. In some cases, the modulation 
of CYPs has been attributed to other minor bioactive 
phenolic compounds and/or their synergistic effects in 
the extract [44]. Our results demonstrated that the in-
duction of CYP1A mRNA expression by the SF extract 
can be attributed to this event since vanillic acid, the 
major phenolic compound of the extract, suppressed 
CYP1A mRNA expression. Xenobiotic responsive ele-
ments (XRE) are located in the promoter regions of 
xenobiotic responsive genes encoding for some CYP 
isozymes. The expression of these genes can be regu-
lated through the aryl hydrocarbon receptor (AhR), 
which is a cytosolic protein that can be activated by 
PAH. The activated AhR then translocates to the nu-
cleus and dimerizes with the AhR nuclear translocator 
(ARNT) and finally interacts with XRE [45]. The in-
duction of CYP1A isozymes by phenolic compounds 
occurs through various mechanisms, including direct 
stimulation of gene expression via specific receptors 
[46]. Some flavonoids induce CYPs by binding to AhR 
by mimicking 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) [47]. Although a variety of flavonoids are 
dietary ligands of the AhR, they can exert different 
effects on CYP expression [48]. Suppression of CYP 
isozymes by the SF extract and vanillic acid could be 
attributed to their binding to the AhR by blocking 
the binding of other AhR ligands, such as TCDD. In 
this context, the SF extract and vanillic acid behave 
as antagonists of AhR. The reason why p-coumaric 
acid did not have any considerable effect on CYP450 
enzymes may be due to its differential structure (it 
does not optimally fit into the binding site on AhR) 
from vanillic acid.
Similarly, CYP2E1 has a wide range of exog-
enous substrates, such as industrial solvents, pro-
toxins and procarcinogens, and some drugs such as 
acetaminophen, chlorzoxazone and methoxyflurane 
are metabolized by CYP2E1 [49]. Thus, inhibition of 
CYP2E1 can prevent the conversion of such procar-
cinogens to their carcinogenic forms such as acryla-
mide, nitrosamine, phenol and benzene. Consequent-
ly, in the present study, the inhibitory mechanisms 
of the SF extract and its major phenolic component 
vanillic acid on CYP2E1 might be regarded as a pro-
tective effect due to the potential suppression of tu-
mor formation, induced by PAHs, drugs and other 
carcinogens. 
Flavonoids in dietary foods were shown to be ef-
fective in the induction of many phase II enzymes, 
including GPx, GSTs and NQO1 [50,51]. The impor-
tance of GST in chemical carcinogen inactivation was 
reported in a study on mice deficient in transcription 
factor Nrf2, which is required for Phase II enzyme in-
duction [52]. In our study, the SF extract and its major 
phenolic compounds, vanillic acid and p-coumaric 
acid, induced the GSTP1 mRNA expression. It seems 
that both phenolic compounds had a major impact 
on the modulation of GSTP1 enzyme. Therefore, the 
induction of GST by the vanillic acid- and p-coumaric 
acid-rich SF extract could help eliminate toxic me-
tabolites from cells and would therefore have an im-
portant role in early defense against carcinogenesis.
GPx has been long been known to play a role in 
the first step of defense against reactive oxygen spe-
cies (ROS). Increased levels of GPx activity could 
enhance the resistance against ROS. It was reported 
that GPx1-overexpressing mice were more resistant 
to paraquat-induced lethality than GPx1 knockout 
mice [53]. Furthermore, increased levels of GPx have 
been shown to have a protective role in cardiovas-
cular diseases, as ROS cause significant changes in 
vascular tone and structure [54]. The SF extract and 
vanillic acid increased the expression of GPx mRNA, 
while p-coumaric acid did not. Therefore, the com-
bined induction of GPx and GSTP1 by the SF extract 
and/or vanillic acid could represent a remarkable en-
hancement of the defense against the toxicity of vari-
ous agents.
The examination of enzyme activities showed 
that the levels of GPx and GSTP1 activities were sig-
nificantly increased by the SF extract. These results 
demonstrate that the modulation of the investigated 
enzymes by the SF extract occurred at gene and en-
zyme activity levels. Moreover, cross analyses of gene 
expression vs. enzyme activity revealed a strict cor-
relation between the mRNA expression levels and 
corresponding enzyme activities in SF-treated and 
control groups.
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CONCLUSIONS
The current state of our knowledge indicates that the 
selective induction of carcinogen-detoxifying enzymes 
and suppression of enzymes responsible for xenobiotic 
activation could be a useful approach in chemopre-
vention and carcinogenesis inhibition. The present 
study demonstrated that the SF methanol extract and 
its major bioactive compound, vanillic acid, exert 
modulatory effects on the expression of the enzymes 
involved in xenobiotic activation and detoxification 
pathways. However, necessary precautions should be 
taken before this plant is consumed in replacement 
treatments because of its possible interactions with 
drugs and dietary foods.
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